Advisors Capital Management’s Allergan plc AGN.PRA Stock Holding History

Advisors Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-25,764	Closed	-$15.1M	–	208
2017 Q4	$15.1M	Buy	25,764 +218	+0.9%	+$141K	1.19%	27
2017 Q3	$18.7M	Buy	25,546 +1,093	+4%	+$907K	1.52%	12
2017 Q2	$21.2M	Buy	24,453 +2,653	+12%	+$2.22M	1.73%	9
2017 Q1	$18.5M	Buy	21,800 +1,753	+9%	+$1.45M	1.59%	13
2016 Q4	$15.3M	Buy	20,047 +1,300	+7%	+$982K	1.46%	17
2016 Q3	$15.4M	Buy	18,747 +2,143	+13%	+$1.85M	1.5%	14
2016 Q2	$13.8M	Buy	16,604 +1,861	+13%	+$1.55M	1.42%	18
2016 Q1	$13.6M	Buy	14,743 +326	+2%	+$312K	1.37%	18
2015 Q4	$14.8M	Buy	14,417 +2,422	+20%	+$2.43M	1.49%	17
2015 Q3	$11.3M	Buy	11,995 +2,184	+22%	+$2.28M	1.24%	22
2015 Q2	$10.3M	Buy	+9,811	New	+$10.3M	1.11%	29

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Advisors Capital Management's AGN.PRA Position: Q1 2018 in Review

Advisors Capital Management sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 25,764 shares — an estimated $15.1M sold.

Advisors Capital Management first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $21.2M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Advisors Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Advisors Capital Management sold 25,764 Allergan plc shares in Q1 2018, an estimated $15.1M.
Advisors Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
Advisors Capital Management's Allergan plc position peaked at $21.2M in Q2 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Advisors Capital Management's 13F filing for Q1 2018, filed 10 May 2018.